title: [Cardiology].
abstract: This article reviews: 1) some of the results of drug eluting stents (SYNTAX and FAME); 2) the questionnable benefit of physical training in heart failure patients (HF-ACTION); 3) the benefit on cardiac remodelling of cardiac resynchronisation in heart failure patients (REVERSE study) and 4) the role of rate over rhythm control in patients with atrial fibrillation and heart failure (AF-CHF study); this article also reports the encouraging evolution of new technology allowing percutaneous implantation of stents-valves. Finally, this article address the screening of athletes for cardiac diseases.
authors.affiliation: Service de cardiologie, CHUV, 1011 Lausanne. Christan.Roguelov@chuv.ch
authors.forename: Christan
authors.initials: C
authors.lastname: Roguelov
authors.forename: Pierre
authors.initials: P
authors.lastname: Vogt
authors.forename: Patrick
authors.initials: P
authors.lastname: Yerly
authors.forename: Patrizio
authors.initials: P
authors.lastname: Pascale
authors.forename: Eugène
authors.initials: E
authors.lastname: Katz
authors.forename: Nicole
authors.initials: N
authors.lastname: Aebischer
mesh_terms: D002304:Cardiac Pacing, Artificial; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000628:therapy*; D003645:Death, Sudden / Q000517:prevention & control; D054855:Drug-Eluting Stents; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D000068799:Prasugrel Hydrochloride; D013177:Sports; D013876:Thiophenes / Q000627:therapeutic use
chemical_list: D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride